A once-a-day tablet for obesity could expand the use of weight-loss drugs to many people who have struggled to access them before, experts have said, after a new study found the pill can lead to ...

Obesity is one of the most stubborn health challenges of our time, linked with diabetes, heart disease, sleep problems, and shortened lifespans. Doctors have long sought treatments that not only help ...

This could really move the needle in the GLP-1 weight loss market. Semaglutide, the active ingredient in Ozempic and Wegovy, is injected into the fatty tissue just under the skin of the stomach, thigh ...

For patients hoping to avoid needles, a pill form of the blockbuster weight-loss drug Wegovy may soon be an option. Novo Nordisk said in a press release that people who took the daily pill in a ...